for Immediate Release
Contact: Claire R. Wynters, Public Relations
-Full-service Contract Research Organization (CRO) incorporates TrialMaster™ into its array of Information Technology Solutions.
(April 18, 2008- Saratoga Springs, NY) – Criterium, Inc., the full service, global, technology driven contract research organization announced today that after successfully working with OmniComm Systems, Inc. on several clinical studies, it has chosen OmniComm’s TrialMaster™ Electronic Data Capture (EDC) solution as its commercial EDC of choice. OmniComm has proven to be a leader in integrated EDC solutions for clinical trials. By choosing to join the OmniComm CRO Preferred Program, Criterium will offer its clients TrialMaster™ EDC as another important instrument in its full-service array of superior products and proprietary processes for collecting data in real-time and managing sites remotely.
“Criterium has been in the business of providing high-quality, global clinical trial support services to the drug development industry for nearly 20 years. We have had the opportunity to become familiar with many of the EDC systems in the marketplace and have chosen TrialMaster™ based on its superior functionality and compatibility with Criterium’s StudyControlTM, our centralized clinical trial data management environment,” said John M. Hudak, President and Founder of Criterium.
“We work successfully with OmniComm. TrialMaster™, along with our other data sources, integrate seamlessly with our data management system. Our workflow is designed to take advantage of the daily receipt of real-time data from our internally developed technology solutions – IVR, FAX scanning, Web enabled forms - and OmniComm’s processes, so that we can obtain and disseminate real-time information about what’s happening in the field. EDC systems only work as well as the site staff inputting data and the CRO staff receiving it. The Criterium- OmniComm team manages the data throughout the process from site entry to database lock with information that is useful for decisionmaking during the study. We appreciate the virtues of a adding a superior EDC product to our mix, and the real dedication to customer service that the OmniComm-Criterium team delivers throughout the process.”
“We are honored that yet another prestigious CRO like Criterium has joined our very successful CRO Preferred Program. Companies are realizing that when they partner with us, we deliver substantial benefits like fixed pricing and complete marketing support that other vendors just don’t offer. Our support allows companies like Criterium to have a competitive edge in the bidding process and the use ofa first class electronic data capture product,” said Stephen Johnson, COO of OmniComm. “It’s a win-win for the CRO, for OmniComm and most importantly the clients that we serve.”
OmniComm Systems, Inc. (www.omniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm’s growing base of satisfied customers is a direct result of the company’s commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm’s client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.
Criterium Inc. is a full service, global and technology driven contract research organization that offers a unique mix of high-quality, innovative clinical research solutions for the biopharmaceutical, and pharmaceutical, medical device and CRO industries. From thought to finish, Criterium provides timely and accurate clinical trial data and support services at every phase of development allowing customers to make sound and cost effective decisions about their clinical trials. Drug development companies can benefit from Criterium’s expertise, high-value services and products and high-end results. Founded in 1991, Criterium’s services are customized to fit each client’s specific needs, providing a seamless flow of data and information from the investigative site through Criterium back to the sponsor. To learn more about the Criterium Edge, visit the website. Criterium has corporate headquarters in Saratoga Springs, New York with offices in Florida, California, South Africa, India, Netherlands, Israel, Russia and Canada.